1. Anti-infection
  2. Bacterial
  3. N-3-oxo-dodecanoyl-L-homoserine lactone

N-3-oxo-dodecanoyl-L-homoserine lactone  (Synonyms: OdDHL)

Cat. No.: HY-114544A Purity: ≥98.0%
SDS COA Handling Instructions

N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL) is a bacterial quorum-sensing signaling molecule produced by P. aeruginosa and strains of the B. cepacia complex.Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density.N-3-oxo-dodecanoyl-L-Homoserine lactone induces the production of IL-8 in 16HBE human bronchial epithelial cells.

For research use only. We do not sell to patients.

N-3-oxo-dodecanoyl-L-homoserine lactone Chemical Structure

N-3-oxo-dodecanoyl-L-homoserine lactone Chemical Structure

CAS No. : 168982-69-2

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 35 In-stock
Solution
10 mM * 1 mL in DMSO USD 35 In-stock
Solid
5 mg USD 32 In-stock
10 mg USD 50 In-stock
50 mg USD 220 In-stock
100 mg USD 390 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL) is a bacterial quorum-sensing signaling molecule produced by P. aeruginosa and strains of the B. cepacia complex[1][2].Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density.N-3-oxo-dodecanoyl-L-Homoserine lactone induces the production of IL-8 in 16HBE human bronchial epithelial cells[3].

Cellular Effect
Cell Line Type Value Description References
DU-145 IC50
19.33 μM
Compound: OdDHL
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
[PMID: 30553142]
EC9706 IC50
> 128 μM
Compound: OdDHL
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
[PMID: 25707012]
Jurkat EC50
250 μM
Compound: 1, OdDHL
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
[PMID: 21488685]
MCF7 IC50
26.24 μM
Compound: OdDHL
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 30553142]
MCF7 IC50
37.31 μM
Compound: OdDHL
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
101.83 μM
Compound: OdDHL
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
29.53 μM
Compound: OdDHL
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 30553142]
NCI-H630 IC50
12 μM
Compound: OdDHL
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
NCI-H630 IC50
34 μM
Compound: OdDHL
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
PC-3 IC50
22.51 μM
Compound: OdDHL
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
[PMID: 30553142]
PC-3 IC50
5 μM
Compound: OdDHL
Cytotoxicity against human PC3 cells after 5 days by SRB assay
Cytotoxicity against human PC3 cells after 5 days by SRB assay
[PMID: 19260689]
SMMC-7721 IC50
> 128 μM
Compound: OdDHL
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
[PMID: 25707012]
Molecular Weight

297.39

Formula

C16H27NO4

CAS No.
Appearance

Solid

Color

White to light yellow

SMILES

CCCCCCCCCC(CC(N[C@@H]1C(OCC1)=O)=O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (336.26 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H2O : < 0.1 mg/mL (insoluble)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.3626 mL 16.8129 mL 33.6259 mL
5 mM 0.6725 mL 3.3626 mL 6.7252 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (8.41 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (8.41 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: ≥98.0%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.3626 mL 16.8129 mL 33.6259 mL 84.0647 mL
5 mM 0.6725 mL 3.3626 mL 6.7252 mL 16.8129 mL
10 mM 0.3363 mL 1.6813 mL 3.3626 mL 8.4065 mL
15 mM 0.2242 mL 1.1209 mL 2.2417 mL 5.6043 mL
20 mM 0.1681 mL 0.8406 mL 1.6813 mL 4.2032 mL
25 mM 0.1345 mL 0.6725 mL 1.3450 mL 3.3626 mL
30 mM 0.1121 mL 0.5604 mL 1.1209 mL 2.8022 mL
40 mM 0.0841 mL 0.4203 mL 0.8406 mL 2.1016 mL
50 mM 0.0673 mL 0.3363 mL 0.6725 mL 1.6813 mL
60 mM 0.0560 mL 0.2802 mL 0.5604 mL 1.4011 mL
80 mM 0.0420 mL 0.2102 mL 0.4203 mL 1.0508 mL
100 mM 0.0336 mL 0.1681 mL 0.3363 mL 0.8406 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

N-3-oxo-dodecanoyl-L-homoserine lactone Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
N-3-oxo-dodecanoyl-L-homoserine lactone
Cat. No.:
HY-114544A
Quantity:
MCE Japan Authorized Agent: